On-the-spot blood lipoprotein(a) testing in pharmacies.
Expand your pharmacy services with lipoprotein(a) - Lp(a) - testing.
The Igloo Reader Pro delivers rapid, reliable results that evaluate Lp(a) level right at the point of care.
Key takeaways
- Lp(a) testing identifies genetic risk factors that contribute to cardiovascular disease.
- High Lp(a) levels indicate increased atherosclerosis risk beyond traditional lipid measurements.
- Rapid, in-pharmacy Lp(a) testing supports personalized patient guidance.
Learn more about our Starter Kit for Pharmacies >
What is Lp(a)?
Lipoprotein(a), or Lp(a), is a genetically determined lipoprotein and an established independent risk factor for atherosclerotic cardiovascular disease, including coronary artery disease, stroke, and aortic valve stenosis. Structurally, Lp(a) resembles low-density lipoprotein (LDL) but contains an additional protein, apolipoprotein(a), bound to apolipoprotein B-100, which contributes to its unique biological behavior and cardiovascular risk profile.
Lp(a) levels vary widely between individuals and are largely inherited, with minimal influence from lifestyle factors. Elevated levels are associated with increased atherosclerosis, inflammation, and thrombosis risk, even when LDL cholesterol is well controlled. Although there is currently no approved therapy specifically targeting Lp(a), testing can help identify individuals who may benefit from more intensive cardiovascular risk management.
Why Lp(a) testing matters in pharmacy?
Lp(a) testing helps identify individuals with inherited cardiovascular risk that is not detected by standard lipid panels, allowing for earlier and more personalized prevention strategies.
Why pharmacies should offer Lp(a) testing:
- Expand cardiovascular risk screening services.
- Identify high-risk individuals who may otherwise be missed.
- Strengthen patient engagement through a personalized approach.
- Create new revenue opportunities through preventive testing services.
How is Lp(a) measured?
- Sample: Blood.
- Units: mg/dL.
Interpretation: Lp(a) levels are primarily genetically determined and can be interpreted independently of other lipid markers. Results should always be interpreted within the clinical context and according to laboratory-specific reference ranges. Always follow the instructions for use (IFU) provided with your testing device and kit to ensure accurate results in your point-of-care setting.
Lp(a) testing with Igloo Reader Pro
Lp(a) can be measured from a small blood sample using the Igloo Reader Pro in pharmacies and other point-of-care settings. Rapid results support cardiovascular risk assessment, particularly for identifying inherited risk not captured by standard lipid panels.
Benefits of Lp(a) testing with the Igloo Reader Pro in pharmacies:
- Provide fast, accurate Lp(a) measurements at the point-of-care.
- Expand cardiovascular risk screening services in-store.
- Integrate testing smoothly into routine pharmacy workflows.
- Enable follow-up services and referrals based on results.
What are normal Lp(a) values?
Lp(a) levels are generally considered normal when below 30 mg/dL.
What is a high Lp(a) level?
High Lp(a) level: >50 mg/dL.
Lp(a) values between 30 and 50 mg/dL are considered intermediate or borderline risk, and levels above 50 mg/dL are associated with increased cardiovascular risk, though reference ranges may vary by laboratory.
It is important to underline that many laboratories have slightly different reference ranges, which can vary based on various factors, so results should always be interpreted within the clinical context. In cases of abnormal Lp(a) levels, pharmacies and other point-of-care health services can offer guidance on lifestyle changes and support, while referring customers to clinicians for personalized evaluation and treatment.
Why pharmacies should offer Lp(a) testing?
Lp(a) testing enables pharmacies to identify inherited cardiovascular risk factors that standard lipid panels may overlook, allowing for earlier detection and personalized prevention strategies. With the Igloo Reader Pro, pharmacies can deliver rapid, accurate Lp(a) results conveniently at the point-of-care, enhancing their role in cardiovascular health screening. This empowers pharmacists to provide timely advice, facilitate appropriate referrals, and strengthen patient engagement in managing long-term heart health.
Learn more about the Pharmacy Starter Kit >
Literature
- Reyes-Soffer et al., Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association, Arteriosclerosis, Thrombosis, and Vascular Biology, 2021, 42-1.
- Farzam et al., Lipoprotein A. In: StatPearls Publishing; 2024.
Disclaimer
This information is educational and does not qualify for a medical advice. Always use local reference ranges and consult a healthcare professional for diagnosis and treatment.
Frequently asked questions
Here are some common questions about diagnostics for pharmacists.
Lp(a) testing measures a genetic risk factor for heart disease not detected by standard lipid tests. It helps identify individuals who need targeted prevention and treatment.
Lp(a) testing reveals inherited cardiovascular risk that standard cholesterol tests can miss, providing a clearer picture of a person’s heart disease risk.
The Igloo Reader Pro enables rapid Lp(a) testing using a small capillary blood sample, with results available in minutes. It is designed for easy integration into pharmacy workflows, helping to deliver timely, accurate information to their customers.
Relevant products
Explore our shop's offerings.